Abbott Biotech Ventures

investment firm

About

Abbott Biotech Ventures makes venture capital investments in emerging biotech and pharmaceutical companies.

Details

Operating Status
Active
Investor Type
Venture Capital

Abbott Biotech Ventures, Inc. (ABVI) is a subsidiary of Abbott dedicated to making venture capital investments in emerging biotech and pharmaceutical companies.

Investments

Number of Investments
Number of Lead Investments
3
1
Abbott Biotech Ventures has made 3 investments. Their most recent investment was on Jan 4, 2012, when NeuroGenetic Pharmaceuticals raised 0.
Date Company Name
Round Money Raised Industry Lead Investor
Series Unknown Biotechnology
Dec 21, 2011 Exicure
Series B $5.40M Biotechnology
Oct 4, 2011 Creabilis
Series B $20M Biotechnology Yes

Exits

Abbott Biotech Ventures has had 2 exits. Abbott Biotech Ventures most notable exits include Exicure ,   Creabilis

Date Company Name Exit Type Industry
Dec 19, 2019 Exicure IPO Biotechnology Detail
Dec 6, 2016 Creabilis M&A Biotechnology Detail